Financhill
Back

BioXcel Therapeutics Vs. Aldeyra Therapeutics Industry Stock Comparison

Sell
25

BTAI
BioXcel Therapeutics

Last Price:
2.71
Seasonality Move:
13.65%
Sell
27

ALDX
Aldeyra Therapeutics

Last Price:
3.95
Seasonality Move:
3.38%
Sell
25
BioXcel Therapeutics (BTAI) is a Sell

Is BioXcel Therapeutics a Buy, Sell or Hold?

  • The current BioXcel Therapeutics [BTAI] share price is $2.71. The Score for BTAI is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • BTAI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Aldeyra Therapeutics (ALDX) is a Sell

Is Aldeyra Therapeutics a Buy, Sell or Hold?

  • The current Aldeyra Therapeutics [ALDX] share price is $3.94. The Score for ALDX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • ALDX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BTAI Stock Price Chart

What is BioXcel Therapeutics's stock price today?

  • The BioXcel Therapeutics share price today is $2.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTAI is experiencing selling pressure, which indicates risk of future bearish movement.

ALDX Stock Price Chart

What is Aldeyra Therapeutics's stock price today?

  • The Aldeyra Therapeutics share price today is $3.94
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALDX is experiencing slight buying pressure.

BTAI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 47.5 Sell
Chaikin Money Flow: -613073 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.64 - 2.86) Sell
Bollinger Bands (100): (2.61 - 3.37) Sell

ALDX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.13 Buy
Relative Strength Index (14 RSI): 53.13 Buy
Chaikin Money Flow: 22635 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.2 - 4.38) Buy
Bollinger Bands (100): (2.97 - 3.87) Buy

BTAI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.73 Sell
20-day SMA: 2.73 Sell
50-day SMA: 2.9 Sell
200-day SMA: 3.99 Sell
8-day EMA: 2.76 Sell
20-day EMA: 2.76 Sell
50-day EMA: 2.87 Sell
200-day EMA: 5.65 Sell

ALDX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.96 Sell
20-day SMA: 4 Sell
50-day SMA: 3.62 Buy
200-day SMA: 4.49 Sell
8-day EMA: 3.97 Sell
20-day EMA: 3.9 Buy
50-day EMA: 3.68 Buy
200-day EMA: 4.42 Sell

BioXcel Therapeutics Earnings Growth & BTAI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.34 per share, and an increase next year of $1.29 per share.

Aldeyra Therapeutics Earnings Growth & ALDX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.46 per share, and a decrease next year of $0.21 per share.

BioXcel Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aldeyra Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):